These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 11364619)

  • 1. Pill treatment for CMV.
    Treat Rev; 1997 Aug; (No 25):7. PubMed ID: 11364619
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CMV trial enrolling.
    Vazquez E
    Posit Aware; 1997; 8(4):13. PubMed ID: 11364480
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ganciclovir implants: one year later.
    Cadman J
    GMHC Treat Issues; 1997; 11(4/5):3-6. PubMed ID: 11364375
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CMV retinitis trial expanding.
    Vazquez E
    Posit Aware; 1998; 9(1):16. PubMed ID: 11364995
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Improved ganciclovir regimens.
    Cadman J
    GMHC Treat Issues; 1997-1998 Winter; 12(1):28-9. PubMed ID: 11364986
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oral ganciclovir.
    Schouten JT
    STEP Perspect; 1995; 7(3):1, 11. PubMed ID: 11362979
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ganciclovir trial is enrolling patients.
    AIDS Patient Care STDS; 1997 Aug; 11(4):293-4. PubMed ID: 11361853
    [No Abstract]   [Full Text] [Related]  

  • 8. CMV treatment.
    Treat Rev; 1995; (no 19):4. PubMed ID: 11362756
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ganciclovir implants (Vitrasert).
    Treat Rev; 1996 Apr; (no 21):10. PubMed ID: 11363393
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CMV, RS-79070: community concern as major drug's development suspended.
    James JS
    AIDS Treat News; 1997 May; (No 270):1-2. PubMed ID: 11364322
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Valganciclovir: new preparation. CMV retinitis: a simpler, oral treatment.
    Prescrire Int; 2003 Aug; 12(66):133-5. PubMed ID: 12906021
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Advances in CMV management: fomivirsen (Vitravene) approved.
    Proj Inf Perspect; 1998 Dec; (26):7. PubMed ID: 11366499
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sustained-release ganciclovir implants represent an effective treatment option for many patients with cytomegalovirus (CMV) retinitis.
    Polk TD; Russell SR; Gehrs KM; Folk JC
    Retina; 1997; 17(5):463-4. PubMed ID: 9355202
    [No Abstract]   [Full Text] [Related]  

  • 14. Eye implants shown superior to IV for retinitis.
    AIDS Alert; 1997 Oct; 12(10):115-7. PubMed ID: 11364717
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treating cytomegalovirus retinitis-related retinal detachment by combining silicone oil tamponade and ganciclovir implant.
    Martidis A; Danis RP; Ciulla TA
    Ophthalmic Surg Lasers; 2002; 33(2):135-9. PubMed ID: 11942545
    [TBL] [Abstract][Full Text] [Related]  

  • 16. First eye implant approved.
    AIDS Alert; 1996 May; 11(5):59. PubMed ID: 11363254
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CMV news.
    Posit Aware; 1996; 7(1):5-6. PubMed ID: 11363124
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oral cytovene an effective alternative to IV.
    AIDS Patient Care; 1995 Dec; 9(6):306. PubMed ID: 11361445
    [No Abstract]   [Full Text] [Related]  

  • 19. Ganciclovir ocular implant: new preparation. May benefit severely affected AIDS patients.
    Prescrire Int; 1998 Jun; 7(35):77-8. PubMed ID: 10342923
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Valganciclovir.
    Curran M; Noble S
    Drugs; 2001; 61(8):1145-50 ; discussion 1151-2. PubMed ID: 11465875
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.